Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





New Research Shows Self-Collected Tests Perform Similarly to Provider-Collected Tests for Detecting STIs

By LabMedica International staff writers
Posted on 27 Jul 2023

New research presented at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo has shown that self-collected tests are as effective as provider-collected tests in detecting prevalent sexually transmitted infections (STIs). These findings could pave the way for new, discreet testing options that expand access to STI screening.

The human papillomavirus (HPV) is a primary cause of cervical cancer in the U.S., creating the need for regular testing as part of prevention and screening measures. Testing traditionally occurs in clinical environments, but there's increasing interest in using self-collected samples for HPV and other STIs. Such self-administered tests could potentially benefit those who find it difficult to access healthcare providers due to their location, profession, or fear of stigma or discrimination. Nevertheless, additional research is needed to confirm the reliability of these self-collected tests.

Researchers from LetsGetChecked Laboratories (New York, NY, USA) and the Permanente Medical Group (Oakland, CA, USA) performed a comparative study on HPV tests using 144 pairs of self-collected vaginal swabs and healthcare provider-collected swabs from the cervix lining. Additionally, they exposed a small selection of self-collected samples to temperatures that simulate extreme seasonal fluctuations. To assess the variability in swabs from a single individual, likely due to differing virus quantities in each swab, the researchers evaluated five self-collected swabs from 15 participants.

Lastly, the team explored methods to enhance the collection process, like modifying the duration samples were left to dry and providing participants with an instructional video. The majority of self-collected samples delivered results consistent with those from provider-collected ones. Differences were attributed to smaller amounts of detectable virus in self-collected samples. Those samples exposed to extreme temperatures had less detectable virus than those not subjected to such conditions. However, changes in the drying time of samples did not affect virus detection. Sample validity saw an improvement of 8.5% after participants viewed an instructional video.

“We performed a detailed analysis of the variables related to self-collected vaginal swabs to calculate analytical acceptability metrics, and to identify limitations in testing that can be improved to aid in modern cervical cancer screening,” said primary author Michelle Qi.

In another study, researchers from the Los Angeles County Department of Public Health (Baldwin Park, CA, USA) and LetsGetChecked analyzed the performance of self-collected tests versus provider-collected tests for two common sexually transmitted infections (STIs): Chlamydia trachomatis and Neisseria gonorrhea. These infections frequently present without symptoms, making them challenging to detect. The Centers for Disease Control and Prevention suggest that self-collected samples, obtained from urine or swabs of the vagina, rectum, or throat, could serve as practical alternatives to provider-collected samples. At present, only urine and vaginal swabs can be self-collected within clinics. This research was initiated with the aim of broadening the inclusivity and accessibility of STI testing by examining more options for self-collection and home testing.

The researchers evaluated results from 164 pairs of rectal swabs collected at home and by providers, and 159 pairs of throat swabs. They also conducted tests on urine and vaginal swabs to determine the effects of temperature fluctuations, contamination from hands, and inaccurate filling of self-collected urine samples. When compared to provider-collected samples, the self-collected rectal swabs showed 95.5% positive agreement for C. trachomatis and a perfect 100% for N. gonorrhea. Meanwhile, self-collected throat swabs were nearly 100% consistent with provider-collected swabs for both infections. Notably, there were several swabs that tested positive for both pathogens when self-collected but tested negative when collected by providers. The presence of hand contaminants had a negligible impact on test outcomes, and the results remained largely unaltered by temperature fluctuations and incorrect filling of urine samples.

“Self-collected rectal and throat swabs could offer better sensitivity than those collected by physicians for detecting C. trachomatis and N. gonorrhea—without compromising the test’s analytical performance,” said Breland Hockman, Ph.D., one of the study’s authors. “Therefore, specimens of STIs collected at home offer a viable option for improving access to STI screening and could offer a non-stigmatizing approach to sexual health.”

Related Links:
LetsGetChecked Laboratories 
Permanente Medical Group 
LA County Public Health 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.